Synchron begin groundbreaking brain implant trials
Synchron CEO and founder Tom Oxley holding the Stentrode implant. Source: Synchron Endovascular brain computer company Synchron has begun US human trials of a brain implant that allows the user to control a computer using thoughts alone. The Stentrode implant is roughly the size of a paperclip and will be trialled on six New York/Pittsburgh…